New HIV medication could help protect women and children aga
Researchers from the University of Carolina have demonstrated the effectiveness of a new anti-HIV medication 4'-Ethynyl-2-fluoro-2'deoxyadenosine or EFdA in preventing oral and vaginal transmission of the virus in animal models,
Their findings, published in the Journal of the Antimicrobial Chemotherapy, suggests that the new medication can be used to help protect women from acquiring HIV and the transmission of the virus from mother to child through breastfeeding.

Read More: